Skip to main content
March 6, 2024 @ 9:49 AM
NASDAQ:KRYS

Krystal Biotech (Ticker: KRYS) is a biotechnology company focused on developing and commercializing gene therapies for rare and debilitating skin diseases. The company's innovative gene therapy platform aims to provide targeted treatments that address the underlying genetic causes of these conditions.

In terms of technical analysis, the stock of Krystal Biotech has achieved our second upside target, indicating a significant price advance. The overall trend of the stock is higher, suggesting a potential continuation of upward momentum.

However, it is worth noting that the stock recently formed an inverted hammer candle at a logical level of potential resistance. This candlestick pattern suggests a potential reversal or consolidation in the stock's price. Traders and investors should closely monitor the stock for any signs of a breakout or further consolidation at this level.

Recent Posts

Technical Analysis of Gap Inc.

June 5, 2024 @ 10:25 AM
NYSE:GPS

Gap Inc. is a leading global retailer that offers clothing, accessories, and personal care products for men, women, and children. With a portfolio of well-known brands including Gap, Old Navy, Banana Republic, and Athleta, Gap Inc.

Technical Analysis of HP Inc.

June 5, 2024 @ 10:21 AM
NYSE:HPQ

HP Inc. is a leading technology company that specializes in providing a wide range of products and solutions for personal computing, printing, and imaging. With a strong presence in the global market, HP Inc.